000 | 01534 a2200445 4500 | ||
---|---|---|---|
005 | 20250510195948.0 | ||
264 | 0 | _c19770812 | |
008 | 197708s 0 0 eng d | ||
022 | _a0026-895X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aU'Prichard, D C | |
245 | 0 | 0 |
_aBinding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. _h[electronic resource] |
260 |
_bMolecular pharmacology _cMay 1977 |
||
300 |
_a454-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdrenergic alpha-Agonists _xmetabolism |
650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBinding Sites _xdrug effects |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 |
_aBrain _xmetabolism |
650 | 0 | 4 |
_aClonidine _xmetabolism |
650 | 0 | 4 |
_aDioxanes _xmetabolism |
650 | 0 | 4 |
_aDioxins _xmetabolism |
650 | 0 | 4 |
_aErgot Alkaloids _xpharmacology |
650 | 0 | 4 |
_aHydroxydopamines _xpharmacology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
650 | 0 | 4 |
_aPhenethylamines _xpharmacology |
650 | 0 | 4 |
_aPhenyl Ethers _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReceptors, Adrenergic _xmetabolism |
650 | 0 | 4 |
_aReceptors, Adrenergic, alpha _xdrug effects |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aGreenberg, D A | |
700 | 1 | _aSnyder, S H | |
773 | 0 |
_tMolecular pharmacology _gvol. 13 _gno. 3 _gp. 454-73 |
|
999 |
_c17062 _d17062 |